Evaluation of cytokines in patients with diabetic retinopathy (DR) is important for the
identification of future additive or alternative treatment options. Therefore, vitreous samples …

Objective: Inflammatory reaction has been shown to involve the progress of type 2 (non-
insulin-dependent) diabetes. We, therefore, examined the effects of inflammatory cytokines …

Purpose: To investigate the expression of various angiogenesis and inflammation mediators
in the vitreous fluid of eyes with proliferative diabetic retinopathy (PDR). Methods: A total of …

Acta Ophthalmol. 2010: 88: e311–e316 Abstract. Purpose: To determine whether the
vitreous levels of interleukin 8 (IL‐8) and vascular endothelial growth factor (VEGF) of …

In this study, we compare the vitreous cytokine profile in patients with proliferative diabetic
retinopathy (PDR) to that of patients without PDR. The identification of novel cytokines …

Objective: To explore the expression profile of angiogenic factors associated with
proliferative diabetic retinopathy (PDR). Methods: Undiluted vitreous humor samples were …

Objective: The objective of the study was to compare cytokine levels in the vitreous body of
patients with proliferative diabetic retinopathy (PDR) undergoing posterior vitrectomy …

Aim To ascertain whether vitreous and plasma levels of vascular endothelial growth factor
(VEGF), interleukin-6 (IL-6) and fundus findings could predict the outcome of vitreous …

Diabetic retinopathy is the leading cause of blindness in working age individuals in
developed countries. However, the role of inflammation in the pathogenesis of DR is not …

AIM To evaluate serum concentrations of angiogenesis-related cytokines in proliferative
diabetic retinopathy (PDR) before and after vitrectomy. METHODS Serum samples were …